Global and China Insulin Market to Register a CAGR of 6.1% by 2019

Diabetes is a chronic metabolic disorder wherein the body is either unable to produce insulin (glucose digesting hormone) or unable to utilize the produced insulin to metabolize blood glucose. This condition results in increased blood glucose level, which leads to various chronic and life-threatening diseases. Insulin is a hormone secreted by ?-cells of pancreas in order to metabolize the blood sugar. The insulin market is a rapidly growing market. Demand for premixed and long-acting insulin derivatives is growing rapidly due to rising incidences of type 1 diabetes. This report focuses on identifying the current scenario as well as the future market potential for insulin globally. Additionally, the insulin market in China is also analyzed and studied thoroughly. The insulin market is segmented based on two important parameters: by mode of action and by source. By mode of action, the market (global and China) is categorized as rapid-acting, short-acting, intermediate-acting, long-acting and premixed insulin derivatives. Furthermore, by source, the market is categorized as human insulin and modern insulin.

Long-acting insulin derivatives is projected to be the fastest growing segment, expanding at a CAGR of 8.7% during the forecast period from 2013 to 2019. According to the World Health Organization (WHO), more than 366 million people worldwide were diagnosed with diabetes in 2011 and an additional 280 million are expected to be diagnosed over the next 20 years. Majority of these patients are likely to be from emerging markets such as China and India.

Download Complete PDF Brochure:


The research report states that the global and China insulin market is expected to grow at a CAGR of 6.10% between 2013 and 2019 to reach US$32.2 bn by the end of 2019, from US$19.9 bn in 2012. The global and China insulin market is segmented on the basis of mode of action and source. The modes of action seen in the insulin market are rapid-acting, long-acting, short-acting, intermediate-acting, and premixed. On the other hand, the sources of insulin are human insulin and modern insulin.

Amongst the types of insulin, the long-lasting insulin segment is expected to grow at a CAGR of 8.70% in the forecast period. This mode of action for managing sugar levels will be popular amongst insulin-dependent diabetics, as only a small dosage is required to bring down blood glucose. Additionally, relatively relaxed regulations regarding the pricing of long-lasting insulin and availability of a wide range of products will also foster the growth of this segment in the overall insulin market.

In 2012, the rapid-acting insulin segment was at the second position in the overall market. In the same period, the premixed insulin segment held a market share of over 50% in the global and China insulin market. In the foreseeable future, intermediate-acting and short-acting insulin are expected to lose ground, as diabetics are shifting preferences and neither of these types of insulin are supported by adequate research and development channels.

Browse Full Research Report:

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.


Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Browse market research blog:

%d bloggers like this: